ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

Shanghai Changzheng Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
locally recurrent colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 857517
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.